2021-01-19

[#DIV28SUPER] FW: Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons

Dear Colleagues,

 

The U.S. Preventive Services Task Force (USPSTF) just released final recommendations and an evidence summary on interventions for tobacco cessation in adults, including pregnant persons. A clinician summary is also available on the Task Force website, which provides guidance to primary care clinicians for using the recommendation in practice.

 

To view the recommendation and evidence summary, please click here:  https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions

 

Please forward to interested colleagues.

 

Thank you.

 

Jacob S. Marzalik, MA

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

 

750 First Street NE, Washington, DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

From: Agency for Healthcare Research and Quality (AHRQ) <updates@subscriptions.ahrq.gov>
Sent: Tuesday, January 19, 2021 11:50 AM
To: Marzalik, Jacob <JMarzalik@apa.org>
Subject: Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons

 

 

u s preventive services task force

January 19, 2021

Final Recommendation Statement:

Interventions for Tobacco Cessation in Adults

Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons

The U.S. Preventive Services Task Force released today a final recommendation statement on interventions for tobacco smoking cessation in adults, including pregnant persons. The Task Force recommends clinicians ask about tobacco use and connect people to proven, safe methods to help them quit. The evidence is unclear whether e-cigarettes help adults quit smoking. More research is needed on the benefits and harms of using medications to help pregnant people quit. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the January 19, 2021 online issue of JAMA.

The Final Recommendation Statement Is Available

read the final recommendation

FINAL RECOMMENDATION SUMMARY

See the full statement

Population

Recommendation

Grade

Nonpregnant adults

The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.

A

Pregnant persons

The USPSTF recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.

A

Pregnant persons

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.

I

All adults

he USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.

I

WHY THIS MATTERS

Michael Silverstein"Quitting is the most important step a smoker can take to lead a longer and healthier life,” says Task Force member Michael Silverstein, M.D., M.P.H. “The good news is there are multiple safe and proven ways to help adults quit tobacco, including counseling, medications, or a combination of both.”

WHERE WE ARE IN THE PROCESS

Draft

Research Plan

Final

Research Plan

Draft

Recommendation / Draft Evidence Review 

Final Recommendation / Evidence Summary


This email was sent to jmarzalik@apa.org using GovDelivery Communications Cloud on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 5600 Fishers Lane, Rockville, MD 20857 · 301-427-1364 


CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.

2021-01-14

[#DIV28SUPER] APA Division 28 wants to highlight YOUR psychopharmacology and substance use research - Abstracts now due Jan 26


Convention Link:

Submission Portal:



Cecilia Bergeria, Ph.D.
Instructor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
P: 410-550-1979

2021-01-13

[#DIV28SUPER] Coordinator II Position Available at the University of Florida

Dear Colleagues,

 

I am hiring a Research Coordinator II in my research group in the Department of Health Education & Behavior at the University of Florida to contribute to our studies on etiology of addictive behaviors and development/testing of new interventions to ameliorate these behaviors, particularly technology-based interventions, primarily (though not exclusively) in the young adult population. This RC II will be in an overseeing and supervisory role so I am looking for someone with prior experience. This person will also contribute to academic tasks like literature searches, potentially preliminary data analysis and collaboration on conference presentations and manuscripts in which we use great words like ameliorate. The link is below. Please spread widely and don’t hesitate to reach out with any questions. As of now, we are a group with three professional/paid research assistants, three doctoral students, an MPH intern and about a dozen undergraduates. I am biased but I feel that we have a good culture where we get along well and work collaboratively.

 

Best,

 

Rob Leeman

 

 

https://explore.jobs.ufl.edu/en-us/job/515453/research-coordinator-ii

 

 

Robert F. Leeman, Ph.D.
Associate Professor

Mary F. Lane Endowed Professor

Department of Health Education and Behavior

College of Health and Human Performance

Co-Director, NIH/NIAAA T32: Translational Science Training to Reduce the Impact of Alcohol on HIV Infection

Associate Director, Southern HIV & Alcohol Research Consortium (SHARC)

University of Florida

Florida Gymnasium, Room 14

PO Box 118210     Gainesville, FL  32611

Phone: (352) 294-1808

Email: robert.leeman@ufl.edu

Faculty webpage: http://hhp.ufl.edu/about/faculty-staff/leeman_robert/

Lab webpage: http://hhp.ufl.edu/faculty-research/labs/edge-lab/

Twitter: @LeemanRobertF

 

 

2021-01-11

[#DIV28SUPER] EXTENDED DEADLINE: APA Division 28 (Psychopharmacology and Substance Abuse) Call for Proposals

Greetings Division 28 members and affiliates,

APA has extended the deadline for abstract submissions by 2 weeks. Proposals are now due by January 26th, 5:00 EST.  Please use this extra time to develop your abstract to present as part of Division 28's programming.

As a reminder, all Divisional programming for this year's meeting will be virtual. This means you will have an easy opportunity to help promote your science and expand your CV without the need for travel. This is a great way to interact with your colleagues and contribute to our mission of promoting rigorous and clinically-impactful science in the area of psychopharmacology and substance use. We are excited to follow up on the tremendous job of our 2020 program chair Justin Strickland to put together an innovative and fun convention program for you but we rely on your submissions to make that happen.

Please email our 2021 Program Chair Dr. Cecilia Bergeria (cberge21@jhmi.edu) or myself as Division 28 President (kdunn9@jhmi.edu) if you need assistance developing or submitting your proposal.


Warm regards,

Kelly Dunn
President, Division 28

---
Kelly Dunn, Ph.D., M.B.A.
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030


From: div28super reaches div28 and div28m and its nested lists (e.g. div28s) <DIV28SUPER@LISTS.APA.ORG> on behalf of Cecilia Bergeria <cberge21@JHMI.EDU>
Sent: Monday, January 4, 2021 3:35 PM
To: DIV28SUPER@LISTS.APA.ORG <DIV28SUPER@LISTS.APA.ORG>
Subject: [#DIV28SUPER] APA Division 28 (Psychopharmacology and Substance Abuse) Call for Proposals
 


Cecilia Bergeria, Ph.D.
Instructor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
P: 410-550-1979

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] 2021 APA Div 28 Awards - Call for Nominations due January 15

 

2021-01-04

[#DIV28SUPER] APA Division 28 (Psychopharmacology and Substance Abuse) Call for Proposals


Links:

Submission Portal:

Cecilia Bergeria, Ph.D.
Instructor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
P: 410-550-1979

[#DIV28SUPER] Seeking Volunteers for APA Division 28 Executive Committee Positions

Greetings Division 28 Colleagues,

I hope you had a wonderful holiday season and that 2021 is starting off well for you. I am writing with two exciting opportunities for you to join the Division 28 Executive Committee.  We are currently recruiting for Fellows Chair and Student Representative positions.  Both terms would be for 3 years (2021-2023) and would entail participation in 1-hr monthly phone calls as well as the job-specific information outlined below.

Benefits to You: This is a great way to grow your CV, contribute meaningfully to the scientific community, and learn scientific leadership skills. Division 28 provides strong networking opportunities with scientists at every stage of the career spectrum and is a good springboard for additional scientific leadership roles. In particular, our division is highly supportive of early career members and have many on our executive committee, which provides a wonderful way to advance your career. We also have several new initiatives planned this year that we believe will energize our divisional members and we value your contribution and input.

Fellows Chair: Requirements: Ideally mid-career or later but would consider enthusiastic early-career members. Being a current Fellow of APA is preferred but not required. Role: Assist prospective Fellow candidates with the application process, which includes securing approval from executive committee members for nomination, obtaining letters of support, and communicating with the APA Fellows Board as needed.  Information about the application process is here: https://www.apa.org/members/your-membership/fellows . The anticipated monthly time-requirement would be 1-3 hours (including monthly calls).

Student Representative: Requirements: Be actively enrolled as a graduate student in the area of psychopharmacology and substance abuse. Role: Provide consult to the executive committee regarding student perspective of various initiatives, contribute to student column in the Division newsletter (published thrice-yearly). The anticipated monthly time-requirement would be 1-2 hours (including monthly calls).

Please email me at Kdunn9@jhmi.edu if you are interested in a position, and provide me with a brief statement of interest and your CV. Applications will be accepted until the positions are filled.

Warm regards and Happy 2021!
Kelly Dunn
---
Kelly Dunn, Ph.D., M.B.A.
President, APA Division 28 (Psychopharmacology and Substance Use)

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030